BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37800812)

  • 1. Comprehensive advancements in the prevention and treatment of diabetic nephropathy: A narrative review.
    Elendu C; John Okah M; Fiemotongha KDJ; Adeyemo BI; Bassey BN; Omeludike EK; Obidigbo B
    Medicine (Baltimore); 2023 Oct; 102(40):e35397. PubMed ID: 37800812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
    Liu XQ; Jiang L; Lei L; Nie ZY; Zhu W; Wang S; Zeng HX; Zhang SQ; Zhang Q; Yard B; Wu YG
    Clin Sci (Lond); 2020 Dec; 134(23):3175-3193. PubMed ID: 33241846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
    Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy, a targeted treatment for diabetic nephropathy.
    Lin X; Tao L; Tang D
    Curr Med Chem; 2013; 20(30):3774-84. PubMed ID: 23895680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities.
    Raval N; Kumawat A; Kalyane D; Kalia K; Tekade RK
    Drug Discov Today; 2020 May; 25(5):862-878. PubMed ID: 31981791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway.
    Zhang H; Yang Y; Wang Y; Wang B; Li R
    Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway.
    Gu LY; Yun-Sun ; Tang HT; Xu ZX
    J Ethnopharmacol; 2021 Dec; 281():113548. PubMed ID: 33152427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting inflammation in diabetic nephropathy: a tale of hope.
    Moreno JA; Gomez-Guerrero C; Mas S; Sanz AB; Lorenzo O; Ruiz-Ortega M; Opazo L; Mezzano S; Egido J
    Expert Opin Investig Drugs; 2018 Nov; 27(11):917-930. PubMed ID: 30334635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.
    Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z
    Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
    Bai Y; Wang J; He Z; Yang M; Li L; Jiang H
    Med Sci Monit; 2019 Apr; 25():3069-3076. PubMed ID: 31023998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic Nephropathy.
    Li X; Li C; Sun G
    J Diabetes Res; 2016; 2016():4065382. PubMed ID: 27379253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Periostin and Nuclear Factor-κB Interplay in the Development of Diabetic Nephropathy.
    Abbad L; Prakoura N; Michon A; Chalghoumi R; Reichelt-Wurm S; Banas MC; Chatziantoniou C
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis: an important player in the inflammatory response in diabetic nephropathy.
    Li J; Li L; Zhang Z; Chen P; Shu H; Yang C; Chu Y; Liu J
    Front Immunol; 2023; 14():1294317. PubMed ID: 38111578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.
    Zeng LF; Xiao Y; Sun L
    Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
    Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y
    Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.
    Rayego-Mateos S; Morgado-Pascual JL; Opazo-Ríos L; Guerrero-Hue M; García-Caballero C; Vázquez-Carballo C; Mas S; Sanz AB; Herencia C; Mezzano S; Gómez-Guerrero C; Moreno JA; Egido J
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-Beta as a Master Regulator of Diabetic Nephropathy.
    Wang L; Wang HL; Liu TT; Lan HY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New susceptibility loci associated with kidney disease in type 1 diabetes.
    Sandholm N; Salem RM; McKnight AJ; Brennan EP; Forsblom C; Isakova T; McKay GJ; Williams WW; Sadlier DM; Mäkinen VP; Swan EJ; Palmer C; Boright AP; Ahlqvist E; Deshmukh HA; Keller BJ; Huang H; Ahola AJ; Fagerholm E; Gordin D; Harjutsalo V; He B; Heikkilä O; Hietala K; Kytö J; Lahermo P; Lehto M; Lithovius R; Osterholm AM; Parkkonen M; Pitkäniemi J; Rosengård-Bärlund M; Saraheimo M; Sarti C; Söderlund J; Soro-Paavonen A; Syreeni A; Thorn LM; Tikkanen H; Tolonen N; Tryggvason K; Tuomilehto J; Wadén J; Gill GV; Prior S; Guiducci C; Mirel DB; Taylor A; Hosseini SM; ; Parving HH; Rossing P; Tarnow L; Ladenvall C; Alhenc-Gelas F; Lefebvre P; Rigalleau V; Roussel R; Tregouet DA; Maestroni A; Maestroni S; Falhammar H; Gu T; Möllsten A; Cimponeriu D; Ioana M; Mota M; Mota E; Serafinceanu C; Stavarachi M; Hanson RL; Nelson RG; Kretzler M; Colhoun HM; Panduru NM; Gu HF; Brismar K; Zerbini G; Hadjadj S; Marre M; Groop L; Lajer M; Bull SB; Waggott D; Paterson AD; Savage DA; Bain SC; Martin F; Hirschhorn JN; Godson C; Florez JC; Groop PH; Maxwell AP
    PLoS Genet; 2012 Sep; 8(9):e1002921. PubMed ID: 23028342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.